VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,992 | -10.6% | 1,226 | 0.0% | 0.02% | -14.3% |
| Q2 2023 | $36,915 | -6.9% | 1,226 | 0.0% | 0.02% | -36.4% |
| Q1 2023 | $39,661 | +113217.1% | 1,226 | 0.0% | 0.03% | -10.8% |
| Q4 2022 | $35 | -99.9% | 1,226 | 0.0% | 0.04% | +5.7% |
| Q3 2022 | $30,000 | -11.8% | 1,226 | 0.0% | 0.04% | -14.6% |
| Q2 2022 | $34,000 | +385.7% | 1,226 | +541.9% | 0.04% | +485.7% |
| Q1 2022 | $7,000 | -79.4% | 191 | -82.2% | 0.01% | -74.1% |
| Q4 2021 | $34,000 | +61.9% | 1,074 | +48.3% | 0.03% | +58.8% |
| Q3 2021 | $21,000 | 0.0% | 724 | +27.5% | 0.02% | +41.7% |
| Q2 2020 | $21,000 | – | 568 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |